Article
FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis
2023-09-17
Abstract excerpt
FGF19 hormone has pleiotropic metabolic functions, notably the modulation of insulin sensitivity, glucose/lipid metabolism and energy homeostasis. On top of its physiological metabolic role, FGF19 has been identified as a potentially targetable oncogenic driver, notably in hepatocellular carcinoma (HCC). Nevertheless, FGF19 remained an attractive candidate for treatment of metabolic disease, prompting the developm...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3d6a4765-420f-5d9b-beaa-372ad36fcdd6
- DOI
- 10.1101/2023.09.15.557921
